News – Page 377 – Endpoints News

GSK drives RSV awareness to center court with Magic Johnson

3 years ago

UK R&D credit increase, faster drug approvals promised in budget speech

3 years ago

Bristol Myers blasts off with SpaceX to study biomanufacturing in space

3 years ago

FDA partially lifts dosing hold on Stoke Therapeutics' pediatric Dravet syndrome study

3 years ago

LadRx starts hunt for new life; Statera lines up merger with diagnostics company

3 years ago

Jounce faces hostile takeover bid from minority stakeholder

3 years ago

German cannabis medicine manufacturer lands $17M+ in funding

3 years ago

Dermavant says Vtama topical cream works in PhIII eczema trial

3 years ago

Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go (corrected)

3 years ago

Bellicum halts trials after serious adverse event, looks for 'strategic alternatives'

3 years ago

Five Pfizer drugs among first 27 now subject to Medicare inflation rebates, HHS says

3 years ago

Five pharmas back $85M Series A for Mediar's fibrosis-modulating antibodies

3 years ago

EU lays out pros and cons to onshoring more API production

3 years ago

Novo Nordisk to cut insulin prices by up to 75% in 2024

3 years ago

EU seeks to incentivize antimicrobial drug development as part of proposed pharma reforms

3 years ago

Ahead of adcomm for full approval, FDA estimates Pfizer's Covid pill could save 1,500 lives per week

3 years ago

PCI Pharma Services to invest $50M to boost production at Illinois campus

3 years ago

FDA warns anesthesiologist for running clinical investigations without an IND

3 years ago

Incyte adds first Opzelura brand TV commercial, and a famous voice, to its vitiligo efforts

3 years ago

MarketingRx roundup: Pfizer, ViiV pull up to champagne carpet at Oscars; Bristol Myers debuts original film

3 years ago

Novartis looks to offload even more of its eye products — report

3 years ago

Further shuffling at Leo Pharma as dermatology drugmaker splits R&D

3 years ago

Servier says its next IDH inhibitor has passed PhIII, but no regulatory timeline yet

3 years ago

Synaffix expands ADC deal from 2022 with MacroGenics

3 years ago

First page Previous page 374 375 376377378 379 380 Next page Last page